Enjoy complimentary customisation on priority with our Enterprise License!
The neurological biomarkers market size is forecast to increase by USD 7.82 billion at a CAGR of 13.01% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of neurological disorders, particularly among the geriatric population. Neurodegenerative conditions, such as multiple sclerosis, are becoming more common as the global population ages and lifestyle-related factors contribute to the rise in neurological disorders. This trend is driving the need for advanced diagnostic tools to accurately identify and monitor neurological conditions, enabling precision medicine and targeted therapies. The unmet market need for effective validation of biomarkers is further fueling market growth. By providing insights into disease progression and response to treatment, neurological biomarkers are transforming the way neurological disorders are diagnosed and managed.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Indication
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.